Nipah (Experimental)
Nipah Virus — Experimental Vaccine Candidates
Platform: Pathogen — No Licensed Vaccine
Bat-borne paramyxovirus with a case fatality rate of 40–75%, classified as a WHO priority pathogen — vaccine candidates are in early trials.
EXPERIMENTAL — No licensed vaccine or therapeutic currently approved.
Immunology Sections
Curated section analysis in progress
Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.
Wikipedia Overview
Full article ↗
Nipah virus is a bat-borne, zoonotic virus that causes Nipah virus infection in humans and other animals, a disease with a very high case fatality rate (40–75%). Numerous disease outbreaks caused by the Nipah virus have occurred in India, Malaysia, and Singapore. Nipah virus belongs to the genus Henipavirus along with the Hendra virus, which has also caused disease outbreaks.
PubMed Literature
Search PubMed ↗No PubMed results retrieved.
Semantic Scholar
Search S2 ↗No Semantic Scholar results retrieved.